Hudson Bay Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Hold	0	–	–	–	915
2022 Q4	–	Sell	-330,000	Closed	-$3.89M	–	1037
2022 Q3	$3.89M	Sell	330,000 -70,000	-18%	-$826K	0.03%	491
2022 Q2	$4.52M	Buy	400,000 +20,000	+5%	+$226K	0.03%	439
2022 Q1	$11.4M	Sell	380,000 -20,000	-5%	-$598K	0.15%	109
2021 Q4	$10.6M	Buy	400,000 +119,000	+42%	+$3.15M	0.11%	113
2021 Q3	$10.2M	Buy	281,000 +31,000	+12%	+$1.13M	0.14%	116
2021 Q2	$10.9M	Sell	250,000 -4,490	-2%	-$195K	0.13%	107
2021 Q1	$8.7M	Sell	254,490 -29,010	-10%	-$992K	0.11%	139
2020 Q4	$9.92M	Sell	283,500 -35,000	-11%	-$1.23M	0.11%	113
2020 Q3	$7.64M	Sell	318,500 -13,385	-4%	-$321K	0.11%	147
2020 Q2	$6.07M	Sell	331,885 -18,115	-5%	-$331K	0.11%	166
2020 Q1	$5.46M	Buy	350,000 +50,000	+17%	+$780K	0.14%	133
2019 Q4	$6.42M	Buy	300,000 +25,000	+9%	+$535K	0.14%	130
2019 Q3	$5.14M	Buy	275,000 +52,000	+23%	+$972K	0.14%	135
2019 Q2	$5.82M	Buy	223,000 +10,000	+5%	+$261K	0.13%	135
2019 Q1	$5.47M	Buy	213,000 +3,000	+1%	+$77.1K	0.07%	136
2018 Q4	$4.83M	Buy	210,000 +14,500	+7%	+$334K	0.06%	166
2018 Q3	$6.28M	Sell	195,500 -4,500	-2%	-$144K	0.08%	123
2018 Q2	$5.66M	Buy	200,000 +75,000	+60%	+$2.12M	0.08%	126
2018 Q1	$4.43M	Hold	125,000	–	–	0.09%	143
2017 Q4	$4.85M	Hold	125,000	–	–	0.1%	115
2017 Q3	$3.18M	Buy	125,000 +25,000	+25%	+$635K	0.08%	149
2017 Q2	$2.73M	Buy	100,000 +85,000	+567%	+$2.32M	0.05%	180
2017 Q1	$497K	Buy	+15,000	New	+$497K	0.01%	339